Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

cancer stem cells

  • You have access
    Role of LLT1 and PCNA as Natural Killer Cell Immune Evasion Strategies of HCT 116 Cells
    JOSEPH D. MALAER and PORUNELLOOR A. MATHEW
    Anticancer Research December 2020, 40 (12) 6613-6621; DOI: https://doi.org/10.21873/anticanres.14686
  • You have access
    Characterization of Pancreatic and Biliary Cancer Stem Cells in Patient-derived Tissue
    JULIA GOGOLOK, ELISABETH SEIDEL, ANNIKA STRÖNISCH, ANJA REUTZEL-SELKE, IGOR M. SAUER, JOHANN PRATSCHKE, MARCUS BAHRA and ROSA B. SCHMUCK
    Anticancer Research March 2020, 40 (3) 1267-1275; DOI: https://doi.org/10.21873/anticanres.14068
  • You have access
    Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells
    HIROHISA OKUYAMA, WATARU NOGAMI, YUJI SATO, HIROSHI YOSHIDA, YUMI TONA and YOSHITAKA TANAKA
    Anticancer Research January 2020, 40 (1) 169-176; DOI: https://doi.org/10.21873/anticanres.13938
  • You have access
    Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells
    MARGARITA V. ROMANENKO, EVGENIYA V. DOLGOVA, IVAN D. OSIPOV, GENRIKH S. RITTER, MARIYA S. SIZOVA, ANASTASIA S. PROSKURINA, YAROSLAV R. EFREMOV, SERGEY I. BAYBORODIN, EKATERINA A. POTTER, OLEG S. TARANOV, VLADIMIR V. OMIGOV, GALINA V. KOCHNEVA, ANTONINA A. GRAZHDANTSEVA, EVGENIY L. ZAVYALOV, IVAN A. RAZUMOV, SERGEY V. NETESOV and SERGEY S. BOGACHEV
    Anticancer Research November 2019, 39 (11) 6073-6086; DOI: https://doi.org/10.21873/anticanres.13815
  • You have access
    The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer
    JANINA OSMAN, KISHAN BELLAMKONDA, QING LIU, TOMMY ANDERSSON and ANITA SJÖLANDER
    Anticancer Research April 2019, 39 (4) 1719-1728; DOI: https://doi.org/10.21873/anticanres.13278
  • You have access
    Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression
    SAWAKO MIYOSHI, HITOSHI TSUGAWA, JUNTARO MATSUZAKI, KENRO HIRATA, HIDEKI MORI, HIDEYUKI SAYA, TAKANORI KANAI and HIDEKAZU SUZUKI
    Anticancer Research November 2018, 38 (11) 6163-6170; DOI: https://doi.org/10.21873/anticanres.12969
  • You have access
    Combination Effects of Hispidin and Gemcitabine via Inhibition of Stemness in Pancreatic Cancer Stem Cells
    NISANSALA CHANDIMALI, DO LUONG HUYNH, WOO YONG JIN and TAEHO KWON
    Anticancer Research July 2018, 38 (7) 3967-3975; DOI: https://doi.org/10.21873/anticanres.12683
  • You have access
    Effect of Tissue Factor on Colorectal Cancer Stem Cells
    HAMISH WILLIAM CLOUSTON, PETER ADAM REES, REBECCA LAMB, SARAH ELIZABETH DUFF and CLIONA CLARE KIRWAN
    Anticancer Research May 2018, 38 (5) 2635-2642;
  • You have access
    Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma
    MAKOTO KAWAMOTO, MASAYO UMEBAYASHI, HIROTO TANAKA, NORIHIRO KOYA, SINICHIRO NAKAGAWA, KEN KAWABE, HIDEYA ONISHI, MASAFUMI NAKAMURA and TAKASHI MORISAKI
    Anticancer Research May 2018, 38 (5) 2739-2748;
  • You have access
    Cancer Progenitor Cells: The Result of an Epigenetic Event?
    KAROLINA LAPINSKA, GABRIELA FARIA, SANDRA MCGONAGLE, KATE MORGAN MACUMBER, SARAH HEERBOTH and SIBAJI SARKAR
    Anticancer Research January 2018, 38 (1) 1-6;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire